LENZ Therapeutics is progressing rapidly with its LNZ100 for presbyopia, aiming for a 2025 U.S. launch in a market valued at ...

Lenz and Davis had a difficult relationship ... She said a significant part of her life had been taken from her — a mother with a free spirit who loved art and horses. After 17 years of ...